Rafi M A, Fugaro J, Amini S, Luzi P, de Gala G, Victoria T, Dubell C, Shahinfar M, Wenger D A
Department of Medicine (Medical Genetics), Jefferson Medical College, Philadelphia, Pennsylvania, 19107, USA.
Biochem Mol Med. 1996 Aug;58(2):142-50. doi: 10.1006/bmme.1996.0042.
Galactocerebrosidase (GALC) is responsible for the lysosomal catabolism of certain galactolipids, including galactosylceramide and psychosine. Patients with GALC deficiency have an autosomal recessive disorder known as globoid cell leukodystrophy (GLD) or Krabbe disease. Storage of undegraded glycolipids results in defective myelin and the characteristic globoid cells observed on pathological examination of the central and peripheral nervous systems. Most patients have the infantile form of GLD, although older individuals are also diagnosed. Recently the human, mouse, and canine GALC genes were cloned, and mutations causing GLD have been identified. We now describe the construction of a vector containing human GALC cDNA (MFG-GALC), and the transduction of cultured skin fibroblasts from molecularly characterized Krabbe disease patients, as well as rat brain astrocytes and human CD34(+) hematopoietic cells, using retrovirus produced by the psi-CRIP amphotropic packaging cell line. The transduced fibroblasts showed extremely high GALC activity (up to 20,000 times pretreatment levels, about 100 times normal). GALC was secreted into the media and was taken up by untransduced fibroblasts from the same or a different patient. Mannose-6-phosphate receptor-mediated uptake was only partially responsible for the efficient transfer of GALC to neighboring cells. Additional studies confirmed the presence of normal GALC cDNA and mRNA in the transduced cells. The GALC produced by the transduced cells and donated to neighboring untransduced cells was localized to lysosomes as demonstrated by the normal metabolism of [14C]stearic acid-labeled galactosylceramide produced from endocytosed [14C]sulfatide.
半乳糖脑苷脂酶(GALC)负责某些半乳糖脂的溶酶体分解代谢,包括半乳糖神经酰胺和鞘氨醇半乳糖苷。GALC缺乏的患者患有一种常染色体隐性疾病,称为球状细胞脑白质营养不良(GLD)或克拉伯病。未降解糖脂的蓄积导致髓鞘缺陷以及在中枢和周围神经系统病理检查中观察到的特征性球状细胞。大多数患者患有婴儿型GLD,不过也有年龄较大的个体被诊断出该病。最近,人类、小鼠和犬类的GALC基因已被克隆,并且已鉴定出导致GLD的突变。我们现在描述一种包含人GALC cDNA的载体(MFG - GALC)的构建,以及使用psi - CRIP双嗜性包装细胞系产生的逆转录病毒对来自分子特征明确的克拉伯病患者的培养皮肤成纤维细胞、大鼠脑星形胶质细胞和人CD34(+)造血细胞进行转导。转导后的成纤维细胞显示出极高的GALC活性(高达预处理水平的20000倍,约为正常水平的100倍)。GALC分泌到培养基中,并被来自同一或不同患者的未转导成纤维细胞摄取。甘露糖 - 6 - 磷酸受体介导的摄取仅部分负责GALC向邻近细胞的有效转移。进一步的研究证实了转导细胞中存在正常的GALC cDNA和mRNA。转导细胞产生并捐赠给邻近未转导细胞的GALC定位于溶酶体,这通过内吞的[14C]硫苷脂产生的[14C]硬脂酸标记的半乳糖神经酰胺的正常代谢得以证明。